Armistice Capital, LLC 13D and 13G filings for Cyclo Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-02-14 2:44 pm Purchase |
2023-12-31 | 13G | Cyclo Therapeutics, Inc. CYTH |
Armistice Capital, LLC | 1,501,625 4.990% |
471,625![]() (+45.79%) |
Filing |
2023-02-14 12:30 pm Unchanged |
2022-12-31 | 13G | Cyclo Therapeutics, Inc. CYTH |
Armistice Capital, LLC | 1,030,000 10.830% |
0 (Unchanged) |
Filing |
2023-02-10 4:28 pm Purchase |
2022-12-31 | 13G | Cyclo Therapeutics, Inc. CYTH |
Armistice Capital, LLC | 1,030,000 10.800% |
814,674![]() (+378.34%) |
Filing |
2020-12-10 7:48 pm Purchase |
2020-12-08 | 13G | Cyclo Therapeutics, Inc. CYTH |
Armistice Capital, LLC | 215,326 4.990% |
215,326![]() (New Position) |
Filing |